Peapack Gladstone Financial Corp held its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,216 shares of the pharmacy operator’s stock at the end of the first quarter. Peapack Gladstone Financial Corp’s holdings in Walgreens Boots Alliance were worth $350,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Nordea Investment Management AB boosted its position in shares of Walgreens Boots Alliance by 26.5% in the first quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock valued at $760,267,000 after buying an additional 1,917,082 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in shares of Walgreens Boots Alliance by 22.9% in the first quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock valued at $407,982,000 after buying an additional 914,888 shares in the last quarter. Swiss National Bank boosted its position in shares of Walgreens Boots Alliance by 27.3% in the first quarter. Swiss National Bank now owns 3,262,703 shares of the pharmacy operator’s stock valued at $270,967,000 after buying an additional 700,400 shares in the last quarter. Canada Pension Plan Investment Board boosted its position in shares of Walgreens Boots Alliance by 28.9% in the first quarter. Canada Pension Plan Investment Board now owns 1,982,013 shares of the pharmacy operator’s stock valued at $164,606,000 after buying an additional 444,900 shares in the last quarter. Finally, Karp Capital Management Corp purchased a new position in shares of Walgreens Boots Alliance during the first quarter valued at $30,227,000. 61.16% of the stock is owned by institutional investors and hedge funds.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded down 1.06% during midday trading on Friday, hitting $80.03. The stock had a trading volume of 5,239,292 shares. The firm has a market cap of $85.64 billion, a P/E ratio of 20.21 and a beta of 1.25. The stock has a 50-day moving average of $79.60 and a 200-day moving average of $82.28. Walgreens Boots Alliance, Inc. has a 52 week low of $75.18 and a 52 week high of $89.69.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.03. The company had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.18 earnings per share. Analysts forecast that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.00%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Wednesday, August 16th. Walgreens Boots Alliance’s payout ratio is 40.30%.
Walgreens Boots Alliance announced that its Board of Directors has approved a share repurchase plan on Thursday, June 29th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to repurchase up to 5.9% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board of directors believes its stock is undervalued.
COPYRIGHT VIOLATION WARNING: This news story was originally posted by BNB Daily and is the sole property of of BNB Daily. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.baseball-news-blog.com/2017/08/19/peapack-gladstone-financial-corp-holds-position-in-walgreens-boots-alliance-inc-nasdaqwba-updated-updated.html.
Several equities research analysts have recently commented on the company. Credit Suisse Group reaffirmed a “buy” rating and set a $97.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, July 13th. Leerink Swann set a $86.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Friday, July 7th. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Thursday, August 3rd. Citigroup Inc. reaffirmed a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Finally, Needham & Company LLC assumed coverage on Walgreens Boots Alliance in a report on Tuesday, June 27th. They set a “hold” rating for the company. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $90.69.
In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now directly owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.